Related Experiment Videos

Staphylococcus aureus Tour, a selectively mouse-pathogenic strain for experimental chemotherapeutic study (a note)

Acta Microbiologica Hungarica
|January 1, 1985
PubMed

Insights

Staphylococcus aureus Tour, a specialized strain, effectively models mouse infections for drug testing. Its high pathogenicity in mice and sensitivity to antibiotics like beta-lactams make it valuable for chemotherapy research.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococcus aureus Tour is a distinct bacterial strain.
  • It exhibits selective pathogenicity, primarily affecting mice.

Purpose of the Study:

  • To highlight the utility of S. aureus Tour in preclinical research.
  • To demonstrate its suitability for chemotherapeutic studies and infection-protection models.

Main Methods:

  • Utilizing S. aureus Tour's selective pathogenicity in mouse models.
  • Assessing Minimum Inhibitory Concentrations (MICs) for beta-lactams and gentamicin.
  • Determining 50% Effective Doses (ED50s) for cephalosporins in infection-protection studies.

Main Results:

  • S. aureus Tour effectively mimics natural infection progression in mice, leading to mortality with low cell counts.
  • The strain shows high sensitivity to beta-lactams and gentamicin (low MICs).
  • It is effective for evaluating cephalosporins in infection-protection models (low ED50s).

Conclusions:

  • S. aureus Tour is a valuable tool for experimental chemotherapeutic studies in mice.
  • Its predictable pathogenicity and antibiotic sensitivity facilitate drug efficacy testing.

Related Concept Videos